RHUMBLINE ADVISERS - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 164 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,185,182
-21.7%
163,985
+1.0%
0.01%
-14.3%
Q2 2023$6,622,957
+120120.7%
162,407
+9.9%
0.01%0.0%
Q1 2023$5,509
+9.4%
147,811
+2.4%
0.01%0.0%
Q4 2022$5,034
-99.9%
144,278
+12.9%
0.01%
-36.4%
Q3 2022$7,153,000
+15.6%
127,830
+6.9%
0.01%
+22.2%
Q2 2022$6,188,000
-13.3%
119,560
+21.7%
0.01%0.0%
Q1 2022$7,140,000
-36.9%
98,247
+2.7%
0.01%
-35.7%
Q4 2021$11,307,000
-14.7%
95,627
-3.2%
0.01%
-22.2%
Q3 2021$13,252,000
-16.9%
98,782
+0.3%
0.02%
-14.3%
Q2 2021$15,943,000
+104.8%
98,467
+1.5%
0.02%
+90.9%
Q1 2021$7,786,000
+40.3%
97,021
-4.9%
0.01%
+37.5%
Q4 2020$5,551,000
+185.1%
102,036
+4.2%
0.01%
+166.7%
Q3 2020$1,947,000
+1.0%
97,927
+6.7%
0.00%0.0%
Q2 2020$1,928,000
+108.4%
91,739
+21.3%
0.00%
+50.0%
Q1 2020$925,000
-9.0%
75,632
+9.2%
0.00%0.0%
Q4 2019$1,016,000
+15.2%
69,274
+4.9%
0.00%0.0%
Q3 2019$882,000
-18.4%
66,045
+0.0%
0.00%0.0%
Q2 2019$1,081,000
+17.5%
66,040
+22.6%
0.00%0.0%
Q1 2019$920,000
+40.0%
53,847
+11.9%
0.00%
+100.0%
Q4 2018$657,000
-23.7%
48,131
+60.0%
0.00%
-50.0%
Q3 2018$861,000
-1.9%
30,081
-6.3%
0.00%0.0%
Q2 2018$878,000
+145.9%
32,106
+89.9%
0.00%
+100.0%
Q1 2018$357,000
+17.8%
16,905
+7.3%
0.00%0.0%
Q4 2017$303,000
-30.2%
15,750
-9.8%
0.00%0.0%
Q3 2017$434,000
+57.8%
17,456
+1.7%
0.00%0.0%
Q2 2017$275,00017,1660.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders